Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hyperthermia 22 Sarcoma 8 Uterine Cervical Neoplasms 7 Breast Neoplasms 6 Rectal Neoplasms 5 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Colonic Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Urinary Bladder Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Carcinoma, Hepatocellular 3 Sarcoma, Synovial 2 Neurofibrosarcoma 2 Liver Neoplasms 2 Liposarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Fibrosarcoma 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1

Interventions

Ibandronic Acid 8 Gemcitabine 8 Doxorubicin 6 Cyclophosphamide 6 Zoledronic Acid 5 Radiation 4 Nivolumab 4 Irinotecan 4 pembrolizumab 3 Vincristine 3 Temozolomide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Denosumab 3 Cisplatin 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 regorafenib 2 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiosurgery 2 Quality of Life 2 Proton Therapy 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Neoplasms × Diathermy × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡